Zobrazeno 1 - 10
of 24 001
pro vyhledávání: '"R. A. Harvey"'
Autor:
Jamie Hakim
Publikováno v:
Communications. 45:509-512
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7224810b986897f51c841a1884884fc6
https://doi.org/10.1515/commun-2019-0171
https://doi.org/10.1515/commun-2019-0171
Publikováno v:
The British Medical Journal, 1966 Jun 01. 1(5501), 1487-1488.
Externí odkaz:
https://www.jstor.org/stable/25408153
Autor:
Christina M. Knippler, Jamie L. Arnst, Isaac E. Robinson, Veronika Matsuk, Tala O. Khatib, R. Donald Harvey, Mala Shanmugam, Janna K. Mouw, Haian Fu, Thota Ganesh, Adam I. Marcus
Publikováno v:
iScience, Vol 27, Iss 4, Pp 109591- (2024)
Summary: Targeting cancer metabolism to limit cellular energy and metabolite production is an attractive therapeutic approach. Here, we developed analogs of the bisbiguanide, alexidine, to target lung cancer cell metabolism and assess a structure-act
Externí odkaz:
https://doaj.org/article/23b5922f597f4f7084cf0f89ddff9f8a
Autor:
Klein, Burton H.
Publikováno v:
Economic Development and Cultural Change, 1991 Jan 01. 39(2), 452-462.
Externí odkaz:
https://www.jstor.org/stable/1154097
Autor:
Dejan Juric, Minal Barve, Ulka Vaishampayan, Desamparados Roda, Aitana Calvo, Noelia Martinez Jañez, Jose Trigo, Alastair Greystoke, R. Donald Harvey, Anthony J. Olszanski, Mateusz Opyrchal, Alexander Spira, Fiona Thistlethwaite, Begoña Jiménez, Jessica Huck Sappal, Karuppiah Kannan, Jason Riley, Cheryl Li, Cong Li, Richard C. Gregory, Harry Miao, Shining Wang
Publikováno v:
Cancer Medicine, Vol 13, Iss 5, Pp n/a-n/a (2024)
Abstract Mivavotinib (TAK‐659/CB‐659), a dual SYK/FLT3 inhibitor, reduced immunosuppressive immune cell populations and suppressed tumor growth in combination with anti‐PD‐1 therapy in cancer models. This dose‐escalation/expansion study inv
Externí odkaz:
https://doaj.org/article/543c6b5130f7472f8fd3b9ea9ea6f7e2
Autor:
Elizabeth Gibson, Sara Lonardi, Christopher Jackson, Armando Santoro, Jose Manuel Trigo Perez, Iwona Lugowska, R Donald Harvey, Anne O’Donnell, Richard North, Loes Maria Latten-Jansen, Marcelo Garrido Salvo, Matías Chacón, Linghui Li, Devanand Joseph, Bryan Bennett, Balmeet Gurm, Wee-Teck Ng, Aitana Calvo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2f70d683c2e141698475c6eae60259f3
Autor:
Anna M. Avinger, Hannah Claire Sibold, Gavin Campbell, Eli Abernethy, John Bourgeois, Tekiah McClary, Shannon Blee, Margie Dixon, R. Donald Harvey, Rebecca D. Pentz
Publikováno v:
BMC Medical Ethics, Vol 24, Iss 1, Pp 1-7 (2023)
Abstract Background Although patient advocates have developed templates for standard consent forms, evaluating patient preferences for first in human (FIH) and window of opportunity (Window) trial consent forms is critical due to their unique risks.
Externí odkaz:
https://doaj.org/article/e9e7fa6552c14fb687d7b39237c750ff
Autor:
Hutchison, Ray
Publikováno v:
American Journal of Sociology, 1988 Sep 01. 94(2), 459-461.
Externí odkaz:
https://www.jstor.org/stable/2780808